Pediatric Surgery Unit, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
Umberto Bosio Center for Digestive Diseases, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
J Laparoendosc Adv Surg Tech A. 2020 Sep;30(9):1023-1028. doi: 10.1089/lap.2020.0250. Epub 2020 Jul 21.
To reoperate a patient with Hirschsprung disease (HSCR) can be technically demanding and most surgeons would resort to conventional laparotomy. This article describes a series of patients with postoperative obstructive symptoms who underwent minimally invasive redo pull-throughs (MIRPT) (either laparoscopic or robotic) to assess the role of minimally invasive surgery (MIS) in complicated HSCR patients. All consecutive HSCR patients with postoperative obstructive symptoms, who underwent MIRPT with fast track concepts of care between January 2012 and January 2020, have been included. Data regarding indications, surgical details, complications, and outcome have been compared to those of a series of patients who underwent conventional laparotomic redo. Sixteen patients were included. Male to female ratio was 4.3:1. Median age at surgery was 78 months. Eleven patients underwent laparoscopic redo and 5 underwent robotic redo. Median length of follow-up was 49 months. Reasons for redoing were transition zone pull-through, residual aganglionosis, anastomotic retraction or leak, rectal diverticulum, and refractory anastomotic stricture. No major intraoperative complication occurred. No conversion to laparotomy was required. One patient experienced cuff stricture requiring laparoscopic release. Two patients reported bouts of enterocolitis postoperatively. Compared to classic laparotomic redo pull-throughs (49 patients with complete data), overall complications were significantly less frequent, accounting for 1 and 21 events, respectively (6% versus 43%) ( = .0067). Continence after a median of 21 months postoperatively scored excellent to good in 9 out of 12 patients, who were assessed on this regard (75%), without statistically significant differences. MIRPT proved to be effective and safe in HSCR patients complaining postoperative obstructive symptoms. Robotic surgery could play a crucial. Our study confirms that complicated HSCR cases can be safely managed by means of MIS, applying concepts of fast track care to serve the best for our patients.
对先天性巨结肠(HSCR)患者进行再次手术可能具有技术挑战性,大多数外科医生会选择传统的剖腹手术。本文描述了一系列术后出现梗阻症状的患者,他们接受了微创再次经肛拖出术(MIRPT)(腹腔镜或机器人),以评估微创外科(MIS)在复杂 HSCR 患者中的作用。所有 2012 年 1 月至 2020 年 1 月期间因术后梗阻症状接受 MIRPT 且采用快速康复护理理念的连续 HSCR 患者均被纳入研究。比较了 MIRPT 患者与接受传统剖腹再次手术患者的手术适应证、手术细节、并发症和预后。纳入了 16 例患者,男女性别比为 4.3:1,手术时中位年龄为 78 个月。11 例患者接受腹腔镜再次手术,5 例患者接受机器人再次手术。中位随访时间为 49 个月。再次手术的原因包括移行段拖出、残留无神经节细胞、吻合口回缩或漏、直肠憩室和难治性吻合口狭窄。无重大术中并发症发生,无需转为开腹手术。1 例患者出现袖口狭窄,需行腹腔镜松解。2 例患者术后出现肠炎发作。与经典的剖腹再次经肛拖出术(49 例患者资料完整)相比,MIRPT 患者的总并发症发生率明显较低,分别为 1 次和 21 次(6%比 43%)( = .0067)。12 例患者中有 9 例(75%)术后中位 21 个月后进行了控便评估,结果显示控便功能极好或良好,无统计学差异。在出现术后梗阻症状的 HSCR 患者中,MIRPT 是一种有效且安全的治疗方法。机器人手术可能发挥关键作用。我们的研究证实,对于复杂的 HSCR 病例,可以通过 MIS 安全地进行治疗,应用快速康复护理理念,为患者提供最佳治疗。